CVS Health Corporation (CVS)
Health Care4 articles
Market Mood
CVS (CVS) Restores Coverage of Zepbound, Adds Eli Lilly's Foundayo
CVS Health (CVS) announced the restoration of coverage for Eli Lilly's (LLY) Zepbound effective October 1 and will add the Foundayo obesity pill on June 1. This adjustment positions Lilly to compete equally with Novo Nordisk in the weight loss market, affecting an estimated 25 million to 30 million Americans. CVS aims for a 10% to 15% increase in savings across weight management treatments with the updated formulary. The decision follows a prior agreement with Novo Nordisk that made Wegovy the favored choice on CVS plans while previously excluding Zepbound.
Read More
CVS Health (CVS) Stock Price Target Raised on Margin Recovery
Mizuho has increased the stock price target for CVS Health (CVS) due to anticipated margin recovery. This revision signifies confidence in the company's ability to improve profitability, which could have a positive effect on its share price. The adjustment reflects ongoing market assessments regarding CVS's performance and operational efficiency. Analysts' price targets are significant indicators of expected market movements and investor sentiment.
Read More
Market Outlook: Earnings Week Ahead for Major Techs and AMD
Jim Cramer indicated that the previous earnings week showed positive results for major tech companies but cautioned that upcoming reports may be challenging. Companies like Advanced Micro Devices (AMD) and Eaton are expected to report strong quarters, with Cramer recommending buying AMD ahead of its earnings. Data center demand, particularly in the context of AI expansion, remains crucial for market performance. Additionally, the labor market is evolving, with artificial intelligence driving productivity and fewer hires, which could have significant implications for Federal Reserve policy.
Read More
US Health Insurers Surge on Medicare Payments Increasing 2.48%
US health insurers, including Humana (HUM), UnitedHealth Group (UNH), and CVS Health (CVS), saw their stocks rise following a Medicare Advantage payment increase. The Centers for Medicare & Medicaid Services (CMS) announced a net average increase of 2.48% in payments for 2027, up from a previously proposed 0.9%. This adjustment is projected to add approximately $13 billion in revenue to private insurers. The higher payments are aimed at providing financial relief amid rising medical costs, with Humana shares rising 6.4%, UnitedHealth by 8.8%, and CVS by 6.6%.
Read More